Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determinants and progression of stigma in amyotrophic lateral sclerosis/motor neuron disease.
Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Bidder C, Edmonds E, Ellis C, Annadale J, Wilde L, Sharrack B, Malaspina A, Leach O, Mills R, Tennant A. Young CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2025 Jan 3:1-11. doi: 10.1080/21678421.2024.2435969. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2025. PMID: 39749679 Free article.
The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease.
Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, Burke G, Pinto A, Dick D, Talbot K, Harrower T, Walsh J, Chandran S, Hanemann CO, Mills R, Tennant A. Young CA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):317-327. doi: 10.1080/21678421.2019.1615951. Epub 2019 May 22. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31116037
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; TONiC Study Group. Young CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):63-70. doi: 10.1080/21678421.2022.2102926. Epub 2022 Jul 23. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35876069
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; Tonic Study Group. Young CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):82-90. doi: 10.1080/21678421.2022.2096410. Epub 2022 Sep 6. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36066075
Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.
Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Talbot K, Malaspina A, Mills R, Tennant A. Young CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):400-409. doi: 10.1080/21678421.2024.2322539. Epub 2024 Mar 1. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38426231 Free PMC article.
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Talbot K, Harrower T, Orrell RW, Annadale J, Hanemann CO, Scalfari A, Tennant A, Mills R; TONIC-ALS STUDY GROUP. Young CA, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Aug;25(5-6):475-485. doi: 10.1080/21678421.2024.2322545. Epub 2024 Mar 11. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38465877 Free PMC article.
Needs and preferences for psychological interventions of people with motor neuron disease.
Weeks KR, Gould RL, Mcdermott C, Lynch J, Goldstein LH, Graham CD, McCracken L, Serfaty M, Howard R, Al-Chalabi A, White D, Bradburn M, Young T, Cooper C, Shaw DPJ, Lawrence V. Weeks KR, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):521-531. doi: 10.1080/21678421.2019.1621344. Epub 2019 Jul 12. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31298054 Free article.
Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK.
Musson LS, Collins A, Opie-Martin S, Bredin A, Hobson EV, Barkhouse E, Coulson MC, Stavroulakis T, Gould RL, Al-Chalabi A, McDermott CJ. Musson LS, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):91-99. doi: 10.1080/21678421.2022.2040533. Epub 2022 Feb 22. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35189760 Free article.
Fit for purpose? A cross-sectional study to evaluate the acceptability and usability of HeadUp, a novel neck support collar for neurological neck weakness.
Sproson L, Lanfranchi V, Collins A, Chhetri SK, Daly N, Ennis M, Glennon L, Gorrie G, Jay E, Marsden R, McCarthy AD, Pryde L, Roberts R, Rutherford A, Ryan J, Stot G, Tindale WB, Shaw PJ, McDermott CJ. Sproson L, et al. Among authors: mcdermott cj. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):38-45. doi: 10.1080/21678421.2020.1813308. Epub 2020 Sep 10. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32909466 Free article.
223 results